Indication
Left Ventricular Diastolic Dysfunction
2 clinical trials
3 products
1 drug
Clinical trial
MB001-067 A PROSPECTIVE, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, RANDOMIZED TRIAL OF EXTENDED RELEASE EXENATIDE VERSUS PLACEBO (COHORT A) AND A PROSPECTIVE, SINGLE GROUP, OPEN-LABEL, BLINDED OUTCOME TRIAL OF EXTENDED RELEASE EXENATIDE (COHORT B) IN DIABETIC PATIENTS WITH TYPE 4 CARDIORENAL SYNDROME (EXTEND-CRS TRIAL) AMENDMENT 3Status: Completed, Estimated PCD: 2019-12-01
Product
BYDUREONDrug
VarlilumabClinical trial
Carvedilol + Simvastatin vs. Carvedilol Alone for Chronic Liver Disease and Cirrhotic Cardiomyopathy and Its Impact on Hepatic Decompensation and Survival; a Double-blind Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Product
SimvastatinProduct
Carvedilol